Advancement in cellular therapies: selected reports from the 37th International Congress organized by the International Society of Blood Transfusion (ISBT) in Kuala Lumpur, June 4–8, 2022

Streszczenie

Hematopoietic stem cells (HSCs) are used in the management of numerous diseases, mainly
for renewal of the hematopoietic system following myeloablative therapy. The cryopreservation
techniques that are currently available allow for safe stem cell storage until transplantation.
The first reports of autologous transplants date back to the 1980s. Since then, significant
advancement in stem cell therapies has been recorded. The subject of this paper are selected
scientific reports related to the collection, preparation and storage of HSCs presented at the 37th
International Society of Blood Transfusion (ISBT) Congress, held in 2022 in Kuala Lumpur